Analysts have set 12-month price targets for 10x Genomics, revealing an average target of $19.67, a high estimate of $28.00, ...
Leerink Partners analyst Puneet Souda has maintained their bullish stance on TXG stock, giving a Buy rating on January 13.Stay Ahead of the ...
Meanwhile, PlutoChain ($PLUTO) could gain attention for its innovative approach to enhancing Bitcoin's capabilities.
Genomics (TXG – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Ryskin from ...
I really don't think Samsung will bring back a 10x optical zoom camera with the Galaxy S25 Ultra. But I'm fine with that ...
Bitcoin is shaping up for a price breakout by the end of January ahead of the United States Federal Open Market Committee ...
Genomics is innovating in spatial technologies but faces hurdles. Discover why TXG stock’s price/cashflow ratio and ...